SciCombinator

Discover the most talked about and latest scientific content & concepts.

K Höschler, J Southern, C Thompson, F Warburton, NJ Andrews, E Miller and M Zambon
Abstract
We report a phase III/IV open-label study on the immunogenicity of a single dose of a Live Attenuated Influenza Vaccine (LAIV) (Fluenz™) in children naïve to, or in previous receipt of, AS03B adjuvanted A/H1N1pdm09 influenza vaccine (Pandemrix™), to investigate whether early exposure to an adjuvanted subunit influenza vaccine impacts on subsequent response to quadrivalent LAIV (qLAIV).
Tweets*
1
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
2009 flu pandemic, Vaccination, Influenza pandemic, Influenza vaccines, Live attenuated influenza vaccine, Vaccine, Influenza, Influenza vaccine
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com